Gottlieb Calls for Changes to Manufacturing Practices to Accelerate Drug Development

Drug Industry Daily
KEYWORDS FDA / GMP
A A

Inadequate manufacturing processes are a main reason for slowdowns in the drug pipeline, a senior FDA official says.

To View This Article:

Login

Subscribe To Drug Industry Daily